title: Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis?
abstract: Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Until now, no randomized, placebo-controlled, long-term trial has tested this drug in individuals with chronic kidney disease who are not receiving dialysis.
authors.forename: Jorge B
authors.initials: JB
authors.lastname: Cannata-Andía
authors.forename: José L
authors.initials: JL
authors.lastname: Fernández-Martín
mesh_terms: D000069449:Cinacalcet; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D054559:Hyperphosphatemia / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006996:Hypocalcemia / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D009281:Naphthalenes / Q000627:therapeutic use*; D006435:Renal Dialysis
chemical_list: D009281:Naphthalenes; D000069449:Cinacalcet